Your browser doesn't support javascript.
loading
Molecular response after obinutuzumab plus high-dose cytarabine induction for transplant-eligible patients with untreated mantle cell lymphoma (LyMa-101): a phase 2 trial of the LYSA group.
Le Gouill, Steven; Beldi-Ferchiou, Asma; Alcantara, Marion; Cacheux, Victoria; Safar, Violaine; Burroni, Barbara; Guidez, Stéphanie; Gastinne, Thomas; Canioni, Danielle; Thieblemont, Catherine; Maisonneuve, Hervé; Bodet-Milin, Caroline; Houot, Roch; Oberic, Lucie; Bouabdallah, Krimo; Bescond, Charles; Damaj, Ghandi; Jaccard, Arnaud; Daguindau, Nicolas; Moreau, Anne; Tilly, Hervé; Ribrag, Vincent; Delfau-Larue, Marie-Hélène; Hermine, Olivier; Macintyre, Elizabeth.
Affiliation
  • Le Gouill S; Service d'hématologie clinique, CHU de Nantes, INSERM CRCINA Nantes-Angers, NeXT Université de Nantes, Nantes, France. Electronic address: steven.legouill@chu-nantes.fr.
  • Beldi-Ferchiou A; Biological Haematology and Immunology Department, Groupe Hospitalier Mondor, Assistance Publique Hôpitaux de Paris, INSERM U955, Paris, France.
  • Alcantara M; Onco-Haematology, Université de Paris, Hôpital and Institut Necker-Enfants Malades, Assistance-Publique-Hôpitaux de Paris, INSERM U1151, Paris, France.
  • Cacheux V; Service d'hématologie clinique du CHU de Clermont-Ferrand, Clermont-Ferrand, France.
  • Safar V; Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Lyon, France.
  • Burroni B; Department of Pathology, Cochin Hospital, Paris, France.
  • Guidez S; Service d'hématologie clinique du CHU de Poitiers, Poitiers, France.
  • Gastinne T; Service d'hématologie clinique, CHU de Nantes, INSERM CRCINA Nantes-Angers, NeXT Université de Nantes, Nantes, France.
  • Canioni D; Onco-Haematology, Université de Paris, Hôpital and Institut Necker-Enfants Malades, Assistance-Publique-Hôpitaux de Paris, INSERM U1151, Paris, France.
  • Thieblemont C; Service d'hémato-oncologie, L'hôpital Saint-Louis AP-HP, Université de Paris, Paris, France.
  • Maisonneuve H; CHD de Vendée, La Roche-Sur-Yon, France.
  • Bodet-Milin C; Service de médecine nucléaire, CHU de Nantes, INSERM CRCINA Nantes-Angers, NeXT Université de Nantes, Nantes, France.
  • Houot R; Service d'Hématologie Clinique, CHU de Rennes, Université de Rennes, INSERM U1236, Rennes, France.
  • Oberic L; Service d'hématologie, IUC Toulouse Oncopole, Toulouse, France.
  • Bouabdallah K; Service d'Hématologie, CHU Bordeaux, Bordeaux, France.
  • Bescond C; Service d'Hématologie, CHU Angers, Angers, France.
  • Damaj G; Haematology Institute, Normandy University School of Medicine, Caen, France.
  • Jaccard A; CHU de Limoges, Limoges, France.
  • Daguindau N; Centre Hospitalier Annecy-Genevois, Epagny Metz-Tessy, France.
  • Moreau A; Service d'anatomo-pathologie, CHU de Nantes, INSERM CRCINA Nantes-Angers, NeXT Université de Nantes, Nantes, France.
  • Tilly H; Département d'Hématologie and U1245, Centre Henri Becquerel, Université de Rouen, Rouen, France.
  • Ribrag V; Département des Innovations Thérapeutiques et Essais Précoces, Université Paris-Saclay, Département d'Hématologie, Gustave Roussy, Université Paris-Saclay, Paris, France.
  • Delfau-Larue MH; Biological Haematology and Immunology Department, Groupe Hospitalier Mondor, Assistance Publique Hôpitaux de Paris, INSERM U955, Paris, France.
  • Hermine O; Department of Adult Haematology, Université de Paris, Hôpital Necker-Enfants Malades, Assistance-Publique, Hôpitaux de Paris, Imagine Institute, INSERM U1153, Paris, France.
  • Macintyre E; Onco-Haematology, Université de Paris, Hôpital and Institut Necker-Enfants Malades, Assistance-Publique-Hôpitaux de Paris, INSERM U1151, Paris, France.
Lancet Haematol ; 7(11): e798-e807, 2020 Nov.
Article in En | MEDLINE | ID: mdl-32971036
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Hematopoietic Stem Cell Transplantation / Lymphoma, Mantle-Cell / Cytarabine / Antibodies, Monoclonal, Humanized Type of study: Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Humans / Middle aged Language: En Journal: Lancet Haematol Year: 2020 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Hematopoietic Stem Cell Transplantation / Lymphoma, Mantle-Cell / Cytarabine / Antibodies, Monoclonal, Humanized Type of study: Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Humans / Middle aged Language: En Journal: Lancet Haematol Year: 2020 Document type: Article